子宫内膜异位症女性心血管结局风险:英国回顾性匹配队列研究
基于英国初级保健数据库的回顾性匹配队列研究,纳入56 090例子宫内膜异位症女性与223 669例匹配对照,随访1995-2018年。子宫内膜异位症与复合心血管病(aHR 1.24)、缺血性心脏病(aHR 1.40)、脑血管病(aHR 1.19)、心律失常(aHR 1.26)和高血压(aHR 1.12)风险升高相关,而全因死亡率降低(aHR 0.66)。
要点
- 子宫内膜异位症女性复合心血管病风险升高(aHR 1.24,95%CI 1.13-1.37)。
- 缺血性心脏病风险升高最明显(aHR 1.40,95%CI 1.22-1.61)。
- 年轻子宫内膜异位症女性是心血管病风险评估和预防的潜在目标人群。
核心结论
- 子宫内膜异位症与心血管结局风险升高相关,年轻患者应作为心血管病风险评估和预防的潜在目标人群。
研究设计与样本
- 基于英国The Health Improvement Network数据库的回顾性匹配队列研究,纳入16-50岁女性,随访1995-2018年。
- 心血管风险分析纳入56 090例子宫内膜异位症女性和223 669例匹配对照。
- 采用多变量Cox回归模型估计调整后风险比(aHR)。
主要发现
- 复合心血管病aHR 1.24(95%CI 1.13-1.37),缺血性心脏病aHR 1.40(95%CI 1.22-1.61)。
- 脑血管病aHR 1.19(95%CI 1.04-1.36),心律失常aHR 1.26(95%CI 1.11-1.43)。
- 高血压aHR 1.12(95%CI 1.07-1.17),全因死亡率aHR 0.66(95%CI 0.59-0.74)。
- 心力衰竭aHR 0.76(95%CI 0.54-1.07)。
- 子宫内膜异位症发病率1998年为12.3/10 000人年,2017年为11.5/10 000人年;患病率从1998年119.7/10 000升至2017年201.3/10 000。
临床怎么用
- 对子宫内膜异位症女性,尤其是年轻患者,应关注并评估心血管病风险。
- 可将子宫内膜异位症病史作为心血管病预防管理的考虑因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the prevalence and incidence of endometriosis and to estimate the risk of cardiovascular outcomes in women with endometriosis. DESIGN: Population-based cohort study using The Health Improvement Network database. SETTING: UK primary care. POPULATION: Women aged 16-50 years were followed from 1995 to 2018. METHODS: Adjusted hazard ratios (aHR) for cardiovascular outcomes comparing women with endometriosis with those without endometriosis were estimated using multivariable Cox regression models. Prevalence and incidence of endometriosis were estimated using annual (1998-2017) sequential cross-sectional and cohort studies, respectively. MAIN OUTCOME MEASURE: The primary outcome was composite cardiovascular disease (CVD) including, ischaemic heart disease (IHD), heart failure (HF) and cerebrovascular disease. Secondary outcomes were arrhythmia, hypertension and all-cause mortality. RESULTS: In all, 56 090 women with endometriosis and 223 669 matched controls without endometriosis were included in the analysis of cardiovascular risk. Compared with women without endometriosis, the aHR for cardiovascular outcomes among women with endometriosis were: composite CVD 1.24 (95% CI 1.13-1.37); IHD 1.40 (95% CI 1.22-1.61); cerebrovascular disease 1.19 (95% CI 1.04-1.36); HF 0.76 (95% CI 0.54-1.07); arrhythmia 1.26 (95% CI 1.11-1.43); hypertension 1.12 (95% CI 1.07-1.17) and all-cause mortality 0.66 (95% CI 0.59-0.74). The incidence of endometriosis was 12.3 per 10 000 person-years in 1998 and 11.5 per 10 000 person-years in 2017. The prevalence of endometriosis increased from 119.7 per 10 000 population in 1998 to 201.3 per 10 000 population in 2017. CONCLUSION: Endometriosis is associated with an increased risk of cardiovascular outcomes. Young women with endometriosis are a potential target for CVD risk assessment and prevention. TWEETABLE ABSTRACT: Endometriosis is associated with increased risk of cardiovascular outcomes: a UK retrospective matched cohort study.
引用
- Okoth K, Wang J, Zemedikun D, et al. Risk of cardiovascular outcomes among women with endometriosis in the United Kingdom: a retrospective matched cohort study. BJOG. 2021. PMID: 33683770. doi:10.1111/1471-0528.16692
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。